Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $6.68, but opened at $7.26. Hyperliquid Strategies shares last traded at $7.1570, with a volume of 2,841,175 shares changing hands.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on PURR shares. Maxim Group assumed coverage on Hyperliquid Strategies in a report on Friday, April 24th. They set a "buy" rating and a $10.00 target price for the company. Cantor Fitzgerald lifted their price target on Hyperliquid Strategies from $8.00 to $18.40 and gave the stock an "overweight" rating in a research note on Wednesday, July 1st. Weiss Ratings upgraded Hyperliquid Strategies from a "sell (d)" rating to a "sell (d+)" rating in a research report on Wednesday, June 3rd. Finally, Chardan Capital reissued a "buy" rating and set a $9.75 price objective on shares of Hyperliquid Strategies in a research note on Friday, June 12th. Three investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, Hyperliquid Strategies currently has a consensus rating of "Moderate Buy" and an average target price of $12.72.
Read Our Latest Stock Report on PURR
Hyperliquid Strategies Stock Up 7.9%
The stock has a market cap of $1.04 billion, a P/E ratio of -0.98 and a beta of 1.71. The firm has a fifty day moving average price of $7.59.
Institutional Trading of Hyperliquid Strategies
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PURR. Bank of America Corp DE purchased a new position in Hyperliquid Strategies during the 2nd quarter valued at $5,001,000. Lotus Technology Management LP bought a new stake in shares of Hyperliquid Strategies during the 2nd quarter valued at about $93,000. EFG International AG purchased a new position in shares of Hyperliquid Strategies during the second quarter valued at about $239,000. Legal & General Group Plc bought a new position in Hyperliquid Strategies in the second quarter worth about $177,000. Finally, The Manufacturers Life Insurance Company purchased a new stake in Hyperliquid Strategies in the second quarter worth about $258,000. Hedge funds and other institutional investors own 9.45% of the company's stock.
Hyperliquid Strategies Company Profile
(
Get Free Report)
Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Hyperliquid Strategies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperliquid Strategies wasn't on the list.
While Hyperliquid Strategies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.